Company Profile
Pharmaffiliates Analytics & Synthetics (P) Ltd, is an integrated Contract Research Organisation (CRO) services provider offering its expertise in Custom synthesis (Reference standards, Impurities, Metabolites, Deuterated compounds and Phyto standards), Analytical research (PH Buffer Solutions, Method development, Validation), Stability studies, Formulation & Development (New Drug Delivery System), Quality assurance and Regulatory services with a right blend of competent people, state of the art infrastructure facilities, cutting-edge technology and certified processes to pump your development pipeline with time and cost advantages. Our expertise will also enable you to combat in the highly competitive markets and also in acquiring the niche segments. We desire to be your strategic partner for outsourcing and help you right from strategic planning of CMC blue-print to accelerating the filing and representation for NDAs and ANDAs submitted in any regulated and semi-regulated markets which can reduce your time and efforts for focusing them in your core areas of operations.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
3-Dehydroxy 2,3-Dehydro Atorvastatin Lactone |
Atorvastatin Dehydro Lactone;3-Dehydroxy 2,3-Dehydro Atorvastatin Lactone;5-(4-fluorophenyl)-1-[2-[(2S)-6-oxo-2,3-dihydropyran-2-yl]ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide;SCHEMBL4980905;ZINC67664918;1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide;1-[2-[(2S)-3,6-Dihydro-6-oxo-2H-pyran-2-yl]ethyl]-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1H-pyrrole-3-carboxamide (Atorvastatin eliminated Lactone);5-(4-fluorophenyl)-2-isopropyl-1-[2-((S)-6-oxo-3,6-dihydro-2H-pyran-2-y1)-ethyl]-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;5-(4-fluorophenyl)-2-isopropyl-1-[2-((S)-6-oxo-3,6-dihydro-2H-pyran-2-yl)-ethyl]-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;5-(4-fluorophenyl)-2-isopropyl-1-[2-((S)-6-oxo-3,6-dihydro-2H-pyran-2-yl)-ethyl]4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
442851-50-5 | Inquiry | |
5-Oxorosuvastatin Methyl Ester |
6-Heptenoic acid,7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-,methyl ester,(3R,6E)-;6-Heptenoic acid,7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-,methyl ester,[R-(E)]-;Methyl (3R,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoate |
147118-39-6 | Inquiry | |
Acyclovir Monophosphate |
acyclo-GMP;acycloguanosine monophosphate;acyclovir monophosphate;UNII-6J91QR22O8;6J91QR22O8;6H-Purin-6-one, 2-amino-1,9-dihydro-9-((2-(phosphonooxy)ethoxy)methyl)-;2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl dihydrogen phosphate |
66341-16-0 | Inquiry | |
Amoxicillin Trihydrate - Impurity C |
4-Thiazolidinecarboxylic acid,2-[5-(4-hydroxyphenyl)-3,6-dioxo-2-piperazinyl]-5,5-dimethyl-;2-[5-(4-Hydroxyphenyl)-3,6-dioxo-2-piperazinyl]-5,5-dimethyl-4-thiazolidinecarboxylic acid;Amoxicillin piperazine-2,5-dione;2,5-Amoxipiperazinedione |
94659-47-9 | Inquiry | |
Atorvastatin Acid - Impurity F |
Atorvastatin N-(3,5-Dihydroxy-7-heptanoic Acid)amide;(3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-Methylethyl)-3-phenyl-4-[(phenylaMino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]aMino]-3,5-dihydroxy-heptanoic Acid CalciuM Salt;Atorvastatin IMpurity-E(EP)(USP RCE);Atorvastatin IMpurity-F(EP);Atovastatin Impurity F;Atorvastatin Diamino |
1105067-87-5 | Inquiry | |
Atorvastatin Acid - Impurity H |
1H-Pyrrole-3-carboxamide,5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-;1H-Pyrrole-3-carboxamide,5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-,(2R-trans)-;5-(4-Fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1H-pyrrole-3-carboxamide;Atorvastatin lactone;Atorvastatin δ-lactone;5-(4-Fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydropyran-2-yl]ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;142062-65-5 |
125995-03-1 | Inquiry | |
Atorvastatin Calcium Salt |
1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),(βR,δR)-;1H-Pyrrole-1-heptanoic acid,2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,calcium salt (2:1),[R-(R*,R*)]-;CI 981;Atorvastatin calcium;YM 548;Lipitor;Atorvastatin hemicalcium;Tahor;Sortis;Atorvastatin hemicalcium salt;Storvas;Rotacor;Atocor;Atoraz;Lowlip;Lorvast;334757-04-9;1108202-55-6;1370463-14-1 |
134523-03-8 | Inquiry | |
Azithromycin - Impurity J |
DesosaMinylazithroMycin;Desosaminylazithromycin (15 mg);(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-2-Ethyl-3,4,10,13-tetrahydroxy-3,5,6,8,10,12,14-heptaMethyl-11-[[3,4,6-trideoxy-3-(diMethylaMino)-β-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentadecan-15-one;CP 66458;DesosaMinylazithroMyc |
117693-41-1 | Inquiry | |
Azithromycin - Impurity L |
Azithromycin N-Oxide (15 mg);(2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-;Azithromycin EP Impurity L;Azithromycin 3-N-Oxide |
90503-06-3 | Inquiry | |
Cefepime - Related Compound D |
4-Thiazoleacetic acid,2-amino-α-(methoxyimino)-,(αZ)-;4-Thiazoleacetic acid,2-amino-α-(methoxyimino)-,(Z)-;(αZ)-2-Amino-α-(methoxyimino)-4-thiazoleacetic acid;Thiazoximic acid;(Z)-2-Amino-α-(methoxyimino)-4-thiazoleacetic acid;2-(2-Amino-4-thiazolyl)-(Z)-2-methoxyiminoacetic acid;syn-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetic acid;2-(2-Aminothiazol-4-yl)-2-(Z)-methoxyiminoacetic acid;2-(2-Aminothiazole-4-yl)-2-(Z)-methoxyiminoacetic acid;(Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetic acid;(Z)-(2-Aminothiazol-4-yl)-α-(methoxyimino)acetic acid;syn-Thiazoximic acid;(Z)-(2-Aminothiazol-4-yl)methoxyiminoacetic acid;(Z)-2-Amino-α-(methoxyimino)-4-thiazoleacetic acid;(Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetic acid;Ansaiwosuan;79226-89-4 |
65872-41-5 | Inquiry | |
Cefpodoxime Proxetil |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester,[6R-[6α,7β(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester,(6R,7R)-;CS 807 (pharmaceutical);CS 807;Cefpodoxime proxetil;U 76252;Antibiotic CS 807;RU 51807;Banan;(RS)-1-(Isopropoxycarbonyloxy)ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-[(Z)-(methoxyimino]acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;Orelox;Vantin;Otreon;Cefodox;Cephpodoxime proxetil;Cepodem;Cefoprox;Cefoflam;Simplicef;95242-58-3 |
87239-81-4 | Inquiry | |
Doxycycline Hyclate |
2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrochloride,(4S,4aR,5S,5aR,6R,12aS)-,compd. with ethanol,hydrate (2:2:1:1);2-Naphthacenecarboxamide,4β-(dimethylamino)-1,4,4aβ,5,5aβ,6,11,12a-octahydro-3,5β,10,12,12aβ-pentahydroxy-6β-methyl-1,11-dioxo-,monohydrochloride,compd. with ethyl alc. (2:1),monohydrate;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride,[4S-(4α,4aα,5α,5aα,6α,12aα)]-,compd. with ethanol (2:1),monohydrate;2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6R,12aS)-,compd. with ethanol (2:1),monohydrate;Ethanol,compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2),monohydrate;Ethanol,compd. with (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2),monohydrate;Doxycycline hydrochloride hemiethanolate hemihydrate;Doxycycline hyclate;6-Desoxy-5-hydroxytetracycline hydrochloride hemihydrate hemiethanolate;Atridox;Periostat;Monodoks;Tetraclean;BioPure MTAD;62149-53-5;1258072-64-8 |
24390-14-5 | Inquiry |